New Talent Is In At Sanofi, Biogen
This article was originally published in The Pink Sheet Daily
Sanofi appointed immunology expert Yong-Jun Liu as head of research, leaving a vacancy at Medimmune, while Biogen recruited its new chief commercial officer Michel Vounatsos from Merck.
You may also be interested in...
Elias Zerhouni says Sanofi's ongoing R&D revamp has produced improved innovative results with controlled spending, in part by emphasizing cutting-edge product development ahead of research.
Revlimid, Copaxone, Sensipar, Enbrel, Acthar Gel and Gleevec will be the subject of a US House Committee on Oversight and Reform in an upcoming drug price hearing.
Pfizer was heavily invested in immuno-oncology combinations five years ago, but following setbacks, the pipeline has shifted considerably, shaped partly by the acquisition of Array.